# Stroke Prevention In Ischemic Stroke With Covert Atrial Fibrillation

Study · id `cardio:ct-nct06486792` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06486792](<https://clinicaltrials.gov/study/NCT06486792>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06486792

Browse, organ or system: Heart; Brain  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1148 participants.

## Technical summary

Registry record NCT06486792. Randomized; single masking; primary purpose treatment. Start 2025-06-18 (actual); primary completion 2028-12-18 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 1148 participants (planned count; ClinicalTrials.gov record NCT06486792, source copy `cardio:ctgov-nct06486792-2026-06-05`, retrieved 2026-10-26)
- Started: 2025-06-18 (actual) (ClinicalTrials.gov record NCT06486792, source copy `cardio:ctgov-nct06486792-2026-06-05`, retrieved 2026-10-26)
- Primary completion: 2028-12-18 (anticipated) (ClinicalTrials.gov record NCT06486792, source copy `cardio:ctgov-nct06486792-2026-06-05`, retrieved 2026-10-26)
- Completion: 2028-12-18 (anticipated) (ClinicalTrials.gov record NCT06486792, source copy `cardio:ctgov-nct06486792-2026-06-05`, retrieved 2026-10-26)
- Countries: France (ClinicalTrials.gov record NCT06486792, source copy `cardio:ctgov-nct06486792-2026-06-05`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06486792-2026-06-05`, retrieved 2026-10-26)

## The registry's words

- Brief title: Stroke Prevention In Ischemic Stroke With Covert Atrial Fibrillation
- Acronym: SPICAF
- Condition: Stroke
- Condition: Ischemic Stroke
- Condition: Cerebral Infarction
- Condition: Atrial Fibrillation
- Intervention (Drug): Apixaban
- Intervention (Drug): Aspirin
- Lead sponsor: Assistance Publique - Hôpitaux de Paris
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry intervention name matches this record: Apixaban (`cardio:apixaban`)
- Registry intervention name matches this record: Aspirin (`core:aspirin`)
- Registry lists this organization as the lead sponsor: Assistance Publique - Hôpitaux de Paris (`cardio:org-assistance-publique-hopitaux-de-paris`)

## Provenance

Content hash: df6b33fbb17f03d8326554c6bd714ead02a4f0e8252026d5fe234ee02ad557a0
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
